POST FORUM SITE
ATTENDEES
​PRESENTERS
INVESTORS
SPONSORS & SUPPORTERS

11.2 Capital
4BIO Capital
Aarhus University
AbbVie, Inc.
Adaptimmune Ltd.
Adimab, LLC
Alpha Bronze
ALSA Holdings Ltd.
Altima Business Solutions
Ample Plus Fund
Astellas Venture Management, LLC
AstraZeneca
BeiGene, Ltd.
BerGenBio ASA
BioCentury
Biocon
BioSense Global LLC
Biotech Alliances International, Inc.
Bloomberg Intelligence
Bloomberg L.P.
Bohe Angel Fund
Boston Immune Technologies & Therapeutics (BITT)
Bpifrance Investissement
Brookline Capital Markets
Cancer Research Institute
Caribou Biosciences, Inc.
Clarivate Analytics
Cleveland Clinic
Connetic Ventures
Cowen, Inc.
Cue Biopharma, Inc.
Daiichi Sankyo, Inc.
Dana-Farber Cancer Institute
Defined Health, a Cello Health business
DiCE Molecules SV, LLC
Eli Lilly & Co.
EMD Serono
ESC Advisors
eTheRNA immunotherapies NV
F-star Biotechnology Ltd.
F. Hoffmann La Roche Ltd.
F1 Oncology, Inc.
F1BioVentures, LLC
Fred Hutchinson Cancer Research Center
FreeMind Group
Genocea Biosciences, Inc.
Genprex, Inc.
GlaxoSmithKline
Grant Park Ventures
Gritstone Oncology
H.C. Wainwright & Co.
Hemispherx Biopharma, Inc.​

Hookipa Biotech AG
Image Analysis Group
Immunicum AB
Immunovaccine, Inc.
ISA Pharmaceuticals B.V.
JAFCO Co., Ltd.
Johnson & Johnson Innovation
Kite Pharma, a Gilead Company
L.E.K. Consulting
Ladenburg Thalmann
Lilly Asian Ventures
Loncar Investment, LLC
Lycera
Madison Vaccines Incorporated
Mediqventures
Merck KGaA
Mergermarket
Milestone Capital
Moffitt Cancer Center
MPM Capital
Nektar Therapeutics
New Science Global Healthcare Fund
Numab Therapeutics AG
Oppenheimer & Co., Inc.
OrbiMed Advisors, LLC
OSE Immunotherapeutics
Pfizer, Inc.
Prevail Partners, LLC
PsiOxus Therapeutics Ltd.
RA Capital Management
RBC Capital Markets
Roche Innovation Centre
RXi Pharmaceuticals, Corp.
Sangel Capital
Selecta Biosciences, Inc.
Selvita S.A.
Suenos Advisors Est.
Tactical Therapeutics, Inc.
Takeda Pharmaceuticals International Co.
TapImmune, Inc.
The Leukemia & Lymphoma Society (LLS)
The Mark Foundation for Cancer Research
Theradex (Europe) Ltd.
Triumvira Immunologics
UNUM Capital
Unum Therapeutics, Inc.
venBio Select
Venn Therapeutics, LLC
Vida Ventures
Vybyl Biopharma
WBB Securities
WG Partners LLP